Addition of an Indoleamine 2,3,-Dioxygenase Inhibitor to B Cell-Depletion Therapy Blocks Autoreactive B Cell Activation and Recurrence of Arthritis in K/BxN Mice
Arthritis & Rheumatism
doi 10.1002/art.34406
Full Text
Open PDFAbstract
Available in full text
Date
June 26, 2012
Authors
Publisher
Wiley